Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 2—February 2009

Research

Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007

Andrew C. SteerComments to Author , Adam Jenney, Joseph Kado, Michael F. Good, Michael Batzloff, Lepani Waqatakirewa, E. Kim Mullholland, and Jonathan R. Carapetis
Author affiliations: University of Melbourne, Melbourne, Victoria, Australia (A.C. Steer, A. Jenney, E.K. Mullholland, J.R. Carapetis); Ministry of Health, Suva, Fiji (J. Kado, L. Waqatakirewa); Queensland Institute of Medical Research, Brisbane, Queensland, Australia (M.F. Good, M. Batzloff); London School of Hygiene and Tropical Medicine, London, UK (E.K. Mullholand); Menzies School of Health Research, Casuarina, Northern Territory, Australia (J.R. Carapetis)

Main Article

Table 1

Case definitions for invasive GAS disease, Fiji, 2005–2007*

Disease Case definition
Definite Either of the following:
1. The isolation of GAS from a normally sterile site (e.g., blood, cerebrospinal fluid, or other sterile fluid/tissue).
2. Clinical presentation of necrotizing fasciitis with evidence of GAS infection (e.g., the presence of typical gram-positive cocci on Gram stain or positive streptococcal serology).
Probable Any of the following:
1. A classic presentation of necrotizing fasciitis without microbiological confirmation.
2. Cellulitis in a patient who is moderately or severely unwell (i.e., unwell and history of parenteral antibiotics and/or admission to hospital) and microbiological confirmation (i.e., group A streptococcal culture of swab or positive streptococcal serology).
3. Other clinically significant infection in a patient who is moderately or severely unwell (i.e., unwell and history of parenteral antibiotics and/or admission to hospital), in conjunction with positive group A streptococcal culture from deep wound swab or biopsy from surgical infection site.

*GAS, group A streptococci.

Main Article

TOP